BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36369817)

  • 1. Negative-pressure wound therapy as an adjunct to treating pyoderma gangrenosum.
    Mulholland O; Middleton D; Hunter H
    J R Coll Physicians Edinb; 2022 Sep; 52(3):260-262. PubMed ID: 36369817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.
    Craig FF; Thomas KS; Mitchell EJ; Williams HC; Norrie J; Mason JM; Ormerod AD;
    Trials; 2012 Apr; 13():51. PubMed ID: 22540770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.
    Ormerod AD; Thomas KS; Craig FE; Mitchell E; Greenlaw N; Norrie J; Mason JM; Walton S; Johnston GA; Williams HC;
    BMJ; 2015 Jun; 350():h2958. PubMed ID: 26071094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portable negative-pressure wound therapy for pyoderma gangrenosum: Report of two cases.
    Yamaguchi Y; Yanagi T; Sato K; Yoshimoto N; Hirata Y; Ujiie I; Nishimura M; Natsuga K; Shiiya C; Tsukinaga I; Shimizu H
    J Dermatol; 2018 Apr; 45(4):483-486. PubMed ID: 29235669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of wound breakdown caused by pyoderma gangrenosum after total knee arthroplasty.
    Nakajima N; Ikeuchi M; Izumi M; Kuriyama M; Nakajima H; Tani T
    Knee; 2011 Dec; 18(6):453-5. PubMed ID: 20643552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the effect of independent, blinded digital image assessment on the STOP GAP trial.
    Patsko E; Godolphin PJ; Thomas KS; Hepburn T; Mitchell EJ; Craig FE; Bath PM; Montgomery AA
    Trials; 2017 Feb; 18(1):53. PubMed ID: 28153051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine.
    Futami H; Kodaira M; Furuta T; Hanai H; Kaneko E
    J Gastroenterol; 1998 Jun; 33(3):408-11. PubMed ID: 9658322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Topical negative pressure and skin transplantation for the treatment of pyoderma gangrenosum].
    Gámiz RC; Nielsen AM
    Ugeskr Laeger; 2011 Aug; 173(35):2132-3. PubMed ID: 21884666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciclosporin compared with prednisolone therapy for patients with pyoderma gangrenosum: cost-effectiveness analysis of the STOP GAP trial.
    Mason JM; Thomas KS; Ormerod AD; Craig FE; Mitchell E; Norrie J; Williams HC;
    Br J Dermatol; 2017 Dec; 177(6):1527-1536. PubMed ID: 28391619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum following an unplanned caesarean section: a patient revisited.
    Ghumra W; Gold A; Azurdia RM
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33619133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoderma gangrenosum after cesarean delivery.
    Rönnau AC; von Schmiedeberg S; Bielfeld P; Ruzicka T; Schuppe HC
    Am J Obstet Gynecol; 2000 Aug; 183(2):502-4. PubMed ID: 10942497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gauze-based negative pressure wound therapy: a valid method to manage pyoderma gangrenosum.
    Fraccalvieri M; Fierro MT; Salomone M; Fava P; Zingarelli EM; Cavaliere G; Bernengo MG; Bruschi S
    Int Wound J; 2014 Apr; 11(2):164-8. PubMed ID: 22891652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recalcitrant oral pyoderma gangrenosum in a child responsive to cyclosporine.
    Park HJ; Han BG; Kim YC; Cinn YW
    J Dermatol; 2003 Aug; 30(8):612-6. PubMed ID: 12928531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The surgical approach to Pyoderma gangrenosum: A retrospective monocenter study.
    Bingoel AS; Krezdorn N; Kaltenborn A; Dastagir K; Jokuszies A; Mett TR; Vogt PM
    Wound Repair Regen; 2021 May; 29(3):478-485. PubMed ID: 33835625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated healing of pyoderma gangrenosum in Behçet patient treated with cyclosporine and split thickness skin graft.
    Kim DW; Lee BI; Park SH
    Ann Plast Surg; 2008 Nov; 61(5):552-4. PubMed ID: 18948785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of flap transplantation combined with vacuum sealing drainage and methylprednisolone and cyclosporine in the treatment of pyoderma gangrenosum.
    Hao Y; He J; Zhao Z; Li C; Feng Z
    Int Wound J; 2023 May; 20(5):1491-1497. PubMed ID: 36321334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pyoderma gangrenosum with topical factor XIII.
    Hoetzenecker W; Guenova E; Mitev V; Schanz S; Ulmer A; Fierlbeck G
    Eur J Dermatol; 2013; 23(5):653-7. PubMed ID: 24135449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile pyoderma gangrenosum.
    McAleer MA; Powell FC; Devaney D; O'Donnell BF
    J Am Acad Dermatol; 2008 Feb; 58(2 Suppl):S23-8. PubMed ID: 18191692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pyoderma gangrenosum: a rare cause of unexpected wound healing delay].
    Henseler H; Menke H; Olbrisch RR
    Chirurg; 2001 Oct; 72(10):1196-200. PubMed ID: 11715624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyoderma gangrenosum successfully treated with split-thickness skin grafting in combination with negative pressure wound therapy: A case report.
    Saito N; Sagara C; Terada A; Akasaka E; Nakano H; Nakajima K; Sawamura D
    J Dermatol; 2024 May; 51(5):e156-e157. PubMed ID: 38009910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.